-- Dietrich Stephan, Ph.D., Co-founder, Navigenics
-- Linda Avey, Co-founder, 23andMe
-- George Church, Ph.D., Professor, Harvard Medical School; Co-founder,
Knome
-- Jeffrey Drazen, M.D., Editor-in-Chief, New England Journal of Medicine
-- Fred Ledley, M.D., Professor and Chair, Bentley College
-- John Halamka, M.D., CIO, Harvard Medical School
"There is extraordinary excitement and interest in the field of personal or
consumer genomics at the moment," commented Bio-IT World's Kevin Davies.
"We are in the first throes of a revolution in medicine and healthcare
thanks to the collapsing costs of gene analysis and the dramatic success of
late in mapping DNA variants that predispose to common disease. We are
thrilled with the caliber of this panel, and anticipate a fascinating,
interactive and highly informative session."
Attendance at the keynote panel and keynote presentations is free (until
April 18) for pre-registered delegates who sign up for an Exhibit and
Keynote pass. Please visit www.bio-itworldexpo.com and click the banner.
Keynote Highlights:
In addition to Linda Avey, Bio-IT World welcomes two other distinguished
keynote speakers:
On Monday, April 28, John Reynders, Ph.D., CIO, Johnson & Johnson, Pharma
R&D, delivers the opening keynote.
On Tuesday, April 29, Joshua Boger, Ph.D., founder, president and CEO,
Vertex Pharmaceuticals, discusses the latest technological issues facing
the drug industry.
Session highlights at this year's event include:
Next-Generation Sequencing Data Management:
You'll get practical information about the analysis, assessment, design,
implementation, testing, and support needed to bring a research
organization from technology adoption to publication in the next-gen world.
This session features guest speakers from Cold Spring Harbor Laboratory,
Broad Institute, Cornell University Biotechnology Resource Center,
Harvard-Lipper Center for Computational Genetics, Naval Medical Research
Center, Intel, BioTeam, Applied Biosystems, Helicos, Illumina, and Roche.
Integrated Framework for Multiple Myeloma Research:
John Quackenbush, Ph.D., Professor of Biostatistics and Computational
Biology, Dana-Farber Cancer Institute will discuss the development of a
novel web-based application to support multiple myeloma research and the
ROI that has been achieved in terms of both cost and science.
Role of Supercomputing in Life Sciences Modeling & Predictive
Bio-simulation: Scientists and technology experts from IBM, Schrödinger
Inc., Gene Network Sciences, Accelrys will discuss how supercomputing can
be applied to drug target validation, virtual screening & lead
optimization, and how modeling and simulation can be integrated with
informatics to enable a comprehensive vision of in silico R&D.
Google Approach to Universal Search for Life Sciences:
Google and Wyeth Pharmaceuticals discuss a new technology application of an
enterprise-wide data search tool that benefits pharma organizations,
improves productivity & collaboration, and provides value.
Now What? Are We Using EDC to Create Its Fullest Possible Business
Benefits? Assumptions and questions exist about the inability of
organizations fully realizing the larger business benefit that EDC and
eClinical trials can bring. Allergan, Millennium Pharmaceuticals, Wyeth
Pharmaceuticals and Waife & Associates, Inc. will present perspectives and
case study examples of successfully leveraging their use of EDC and the
actionable knowledge it has created.
For more information on Bio-IT World Conference & Expo, visit the event Web
site at www.bio-itworldexpo.com.
About Bio-IT World www.bio-itworld.com
Bio-IT World -- the flagship publication of CHI -- is the leading source of
news on technology and strategic innovation in drug discovery, development,
and clinical trials. Bio-IT World's focus is increasingly one that explores
the tools and results of "predictive biology" as the industry adapts to the
new world of "personalized medicine." Bio-IT World has won 34 national and
regional awards, more than any other magazine covering the life sciences
industry. Bio-IT World was acquired by CHI in 2006 and is part of the
Cambridge Healthtech Media Group -- a new group introduced by CHI in August
2007 -- that offers a suite of published resources that include Bio-IT
World magazine, numerous topic-specific eNewsletters, and comprehensive,
continually updated web sites.
About CHI www.healthtech.com
Founded in 1992, Cambridge Healthtech Institute (CHI) is the industry
leader offering the preeminent source of information to the leading
researchers and business experts from top pharmaceutical, biotech, and
academic organizations. Delivering an assortment of resources such as
events, reports, publications and eNewsletters, CHI's portfolio of products
include Cambridge Healthtech Institute Events, Pharmaceutical Strategy
Series, Insight Pharma Reports, Marketing Services, and Cambridge
Healthtech Media Group.
Contact Information: Contact: Kaushik Chaudhuri Cambridge Healthtech Institute (781) 972-5419